top of page

The Hidden Dangers of Joint Injections for Horses: Lessons from Human Medicine

In the realm of equine health, joint injections are a common practice aimed at alleviating discomfort and aiding in the recovery of injured horses. However, beneath the surface lies a complex web of risks and potential harm, drawing parallels to the cautionary tales found in human medicine. Let's delve into the intricacies of joint injections for horses, the detrimental effects of corticosteroids, and the striking similarities between equine and human joint anatomy.

Corticosteroids, the primary agents used in joint injections for both humans and horses, have long been hailed for their anti-inflammatory properties. Yet, their mechanism of action can be a double-edged sword. These powerful compounds operate by suppressing the immune response and inhibiting inflammation. However, their indiscriminate nature means they can wreak havoc on healthy cells and tissues, leading to a cascade of destructive effects [8].

In equine joints, the injection of corticosteroids can spell disaster for the delicate balance of tissue repair. These substances work catabolically, breaking down tissues instead of fostering healing. The very cells tasked with regeneration become casualties in the battle against inflammation, hindering the body's natural ability to repair damaged structures. Research in equine medicine underscores these concerns, highlighting the potential for long-term joint damage and compromised healing outcomes [1].

Remarkably, human medicine offers a cautionary tale that echoes the risks associated with corticosteroid injections. While these interventions are employed judiciously in specific cases, the inherent dangers are well-documented. Unlike in equine medicine, where joint injections are more liberally administered, human patients are subject to stringent guidelines to mitigate risks. The frequency of injections is limited, with individuals typically restricted to a handful over a lifetime [2].

The anatomy of equine and human joints reveals striking similarities at the cellular level, underscoring the relevance of insights gleaned from human research. Both species possess synovial joints characterized by a synovial membrane, articular cartilage, and a joint capsule housing synovial fluid. Within this intricate framework lie chondrocytes, the specialized cells responsible for maintaining cartilage integrity and facilitating repair [3].

Despite these shared features, the repercussions of joint injections can vary between species. Equine athletes, reliant on sound musculoskeletal health for performance, face heightened risks of joint deterioration following corticosteroid administration [4]. The cumulative effects of repeated injections can exacerbate existing injuries, compromising the longevity of competitive careers and overall well-being [6].

In light of these considerations, a paradigm shift is warranted in the approach to joint health in equine medicine. Embracing alternative modalities that prioritize tissue regeneration over suppression of inflammation holds promise for optimizing outcomes. Platelet-rich plasma (PRP) therapy and stem cell treatments offer avenues for harnessing the body's innate healing mechanisms without the deleterious effects associated with corticosteroids [5].

However, even in the context of platelet-rich plasma (PRP) therapy, where the focus is on harnessing the body's healing potential, the very act of needle insertion warrants careful consideration. Research has indicated that needle trauma during joint injections, including those for PRP, can compromise the integrity of the joint capsule, potentially leading to intra-articular bleeding and exacerbating existing damage [9]. Therefore, while PRP therapy offers promise in promoting tissue regeneration, practitioners must exercise caution to minimize the risk of iatrogenic injury during the administration process.

In conclusion, the dangers and risks of joint injections for horses serve as a cautionary tale rooted in parallels with human medicine. Corticosteroids, while potent in their anti-inflammatory actions, exact a toll on healthy tissues and impede the healing process. By acknowledging the shared vulnerabilities of equine and human joints, we can pivot towards interventions that promote long-term musculoskeletal health and uphold the welfare of our equine companions.


  1. McIlwraith CW, Lattermann C. Intra-articular Corticosteroids for Knee Pain-What Have We Learned from the Equine Athlete and Current Best Practice. J Knee Surg. 2019 Jan;32(1):9-25. doi: 10.1055/s-0038-1676449. Epub 2018 Dec 18. PMID: 30562835.

  2. McAlindon TE, et al. (2017). OARSI guidelines for the non-surgical management of knee osteoarthritis.

  3. McIlwraith CW, et al. (2011). Equine synovial joint anatomy: comparison of common structures and a proposed new system.

  4. Frisbie DD, et al. (2020). Equine Athletes: The Importance of Regenerative Medicine in Maintaining Performance.

  5. Van den Boom R, et al. (2021). Biological treatments for equine joint disease: A comparative review.

  6. Kompel A.J., Roemer F.W., Murakami A.M., Diaz L.E., Crema M.D., Guermazi A. Intra-articular corticosteroid injections in the hip and knee: Perhaps not as safe as we thought? Radiology. 2019;293:656–663. doi: 10.1148/radiol.2019190341

  7. Nizolek DJ, White KK. Corticosteroid and hyaluronic acid treatments in equine degenerative joint disease. A review. Cornell Vet. 1981 Oct;71(4):355-75. PMID: 7032840.

  8. Harkins JD, Carney JM, Tobin T. Clinical use and characteristics of the corticosteroids. Vet Clin North Am Equine Pract. 1993 Dec;9(3):543-62. doi: 10.1016/s0749-0739(17)30385-1. PMID: 8299015.

  9. Jianguo Cheng, Salahadin Abdi. Complications of joint, tendon, and muscle injections. Techniques in Regional Anesthesia and Pain Management, Volume 11, Issue 3, 2007, Pages 141-147, ISSN 1084-208X,


bottom of page